Heart Valve Diseases
Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
Subtype terms (10)
More specific conditions that are subtypes of Heart Valve Diseases in the MeSH hierarchy.
- Aortic Valve Disease
48 drugs (36 approved, 12 experimental)
- Heart Valve Prolapse
- Mitral Valve Insufficiency
24 drugs (20 approved, 4 experimental)
- Mitral Valve Stenosis
14 drugs (11 approved, 3 experimental)
- Pulmonary Atresia
2 drugs (1 approved, 1 experimental)
- Pulmonary Valve Insufficiency
1 drug approved
- Pulmonary Valve Stenosis
2 drugs (1 approved, 1 experimental)
- Tricuspid Atresia
5 drugs approved
- Tricuspid Valve Insufficiency
9 drugs (6 approved, 3 experimental)
- Tricuspid Valve Stenosis
Drugs by status
Phase 4 trials (32)
- ringer's lactate
- ferric derisomaltose
- propofol
- heparin
- sintrom
- alfacalcidol
- calcium carbonate
- acetylcysteine
- dabigatran
- ketamine
- sevoflurane
- albumin (Human)
- warfarin
- etomidate
- levosimendan
- human factor ix complex (prothrombin complex concentrate)
- ropivacaine
- magnesium sulfate
- sevelamer
- acetylsalicylic acid
- thiopental
- enoxaparin
- phenprocoumon
- dexmedetomidine
- fentanyl
- losartan
- metoprolol
- sildenafil
- tranexamic acid
- blood plasma
- +2 more
Phase 3 trials (8)
Phase 2 trials (17)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (19)
- AstraZeneca
- Boehringer Ingelheim
- Hospital General Universitario Gregorio Marañon
- Mahidol University
- Mansoura University
- Postgraduate Institute of Medical Education and Research
- University of Tampere
- University of Bern
- Yonsei University
- Mayo Clinic
- University of Ulsan
- University of Vienna
- Konkuk University
- University of Sao Paulo
- Kuopio University Hospital
- University of Western Ontario
- Government of Finland
- Fundación de Investigación en Red en Enfermedades Cardiovasculares
- Universidad Carlos III Madrid
Organization Involved with Phase 3 Indications (14)
- Bayer
- ECRI bv
- Federal University of Bahia
- Hospital Universitari Son Dureta
- Urmia University of Medical Sciences
- Austin Health
- University of British Columbia
- University of Copenhagen
- Universidad Autonoma de Barcelona
- Heart and Stroke Foundation of Canada
- Cardialysis BV
- BIOMED
- People's Liberation Army of China
- Hospital Geral Roberto Santos
Organization Involved with Phase 2 Indications (18)
- CSL Behring
- Critical Therapeutics
- Dong-A Pharmaceutical
- Hamilton Health Sciences Corporation
- United States Army
- William Beaumont Hospitals
- Maastricht University
- Dartmouth University
- Emory University
- Hospital do Coracao
- McMaster University
- Oakland University
- Russian Academy of Medical Sciences
- University of Leicester
- University of Maryland
- Assiut University
- The Physicians' Services Incorporated Foundation
- Essential Pharmaceuticals, LLC
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (13)
- Roche
- Huazhong University of Science and Technology
- Johns Hopkins University
- Ohio State University
- University of Michigan
- Capital Medical University
- University of Utah
- University of Maribor
- University of Lyon
- Sun Yat-Sen University
- National Natural Science Foundation of China
- Government of France
- Chinese Academy of Medical Sciences